Lawrence E. Bloch

2015

In 2015, Lawrence E. Bloch earned a total compensation of $1.8M as Chief Financial Officer and Chief Business Officer at Infinity Pharmaceuticals, a 118% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$121,800
Option Awards$1,233,275
Salary$405,385
Other$8,953
Total$1,769,413

Bloch received $1.2M in option awards, accounting for 70% of the total pay in 2015.

Bloch also received $121.8K in non-equity incentive plan, $405.4K in salary and $9K in other compensation.

Rankings

In 2015, Lawrence E. Bloch's compensation ranked 5,236th out of 13,638 executives tracked by ExecPay. In other words, Bloch earned more than 61.6% of executives.

ClassificationRankingPercentile
All
5,236
out of 13,638
62nd
Division
Manufacturing
1,937
out of 5,190
63rd
Major group
Chemicals And Allied Products
704
out of 1,854
62nd
Industry group
Drugs
559
out of 1,528
63rd
Industry
Pharmaceutical Preparations
439
out of 1,182
63rd
Source: SEC filing on April 25, 2016.

Bloch's colleagues

We found five more compensation records of executives who worked with Lawrence E. Bloch at Infinity Pharmaceuticals in 2015.

2015

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2015

Sujay Kango

Infinity Pharmaceuticals

Chief Commercial Officer

2015

Julian Adams

Infinity Pharmaceuticals

President of R&D

2015

David Roth

Infinity Pharmaceuticals

Chief Medical Officer

2015

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

News

In-depth

You may also like